- Home
- ANGO vs ABSI Comparison
ANGO vs ABSI Comparison
Compare ANGO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- ABSI
- Stock Information
- Founded
- ANGO 1988
- ABSI 2011
- Country
- ANGO United States
- ABSI United States
- Employees
- ANGO N/A
- ABSI N/A
- Industry
- ANGO Medical/Dental Instruments
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ANGO Health Care
- ABSI Health Care
- Exchange
- ANGO Nasdaq
- ABSI Nasdaq
- Market Cap
- ANGO 439.5M
- ABSI 353.8M
- IPO Year
- ANGO 2004
- ABSI 2021
- Fundamental
- Price
- ANGO $9.11
- ABSI $2.75
- Analyst Decision
- ANGO Strong Buy
- ABSI Strong Buy
- Analyst Count
- ANGO 2
- ABSI 5
- Target Price
- ANGO $14.00
- ABSI $8.40
- AVG Volume (30 Days)
- ANGO 330.9K
- ABSI 2.5M
- Earning Date
- ANGO 04-02-2025
- ABSI 05-13-2025
- Dividend Yield
- ANGO N/A
- ABSI N/A
- EPS Growth
- ANGO N/A
- ABSI N/A
- EPS
- ANGO N/A
- ABSI N/A
- Revenue
- ANGO $283,320,000.00
- ABSI $4,534,000.00
- Revenue This Year
- ANGO N/A
- ABSI $158.58
- Revenue Next Year
- ANGO $6.35
- ABSI $93.12
- P/E Ratio
- ANGO N/A
- ABSI N/A
- Revenue Growth
- ANGO N/A
- ABSI N/A
- 52 Week Low
- ANGO $5.47
- ABSI $2.01
- 52 Week High
- ANGO $13.50
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- ANGO 46.41
- ABSI 42.92
- Support Level
- ANGO $8.55
- ABSI $2.85
- Resistance Level
- ANGO $9.68
- ABSI $2.94
- Average True Range (ATR)
- ANGO 0.36
- ABSI 0.19
- MACD
- ANGO -0.02
- ABSI -0.03
- Stochastic Oscillator
- ANGO 46.28
- ABSI 14.13
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.